13F-HR filed by Prosight Management, LP
Prosight Management, LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-13 21:13:55 UTC, with 32 holding rows worth $515,482,740.
- Accession
- 0001420506-26-002713
- Filer
- CIK 1617201
- Filed
- 2026-11-13
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 32 entries on the cover page, a total value of $515,482,740 stated on the cover page (in dollars after the unit check, H1), rows summing to $515,482,740 with VALUE read as dollars as filed, 13F file number 028-18450. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 1,998,400 | $59,252,560 | dollars as filed | |
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 7,648,094 | $52,160,001 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 2,943,200 | $50,858,496 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 785,000 | $47,527,825 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 376,794 | $37,310,142 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 238,088 | $27,175,364 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 550,000 | $24,007,500 | dollars as filed | |
| IRHYTHM HOLDINGS INC COM | 450056106 | Stock | 200,980 | $22,843,387 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 550,000 | $22,286,000 | dollars as filed | |
| PRIVIA HEALTH GROUP INC | 74276R102 | COM | 1,049,752 | $20,669,617 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 800,000 | $20,104,000 | dollars as filed | |
| ZYMEWORKS INC | 98985Y108 | COM | 721,100 | $19,101,939 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 812,582 | $15,276,542 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 1,275,000 | $13,655,250 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 550,700 | $11,382,969 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 36,400 | $10,600,772 | dollars as filed | |
| HEALTHEQUITY INC COM | 42226A107 | Stock | 115,796 | $10,243,314 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 150,000 | $9,870,000 | dollars as filed | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 37,000 | $9,129,380 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 22,000 | $8,394,540 | dollars as filed | |
| ENOVIS CORPORATION | 194014502 | COM | 267,432 | $4,885,983 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 1,325,570 | $3,612,178 | dollars as filed | |
| QUANTERIX CORP | 74766Q101 | COMMON STOCK | 825,000 | $3,060,750 | dollars as filed | |
| GENERATE BIOMEDICINES INC | 370920100 | COMMON STOCK | 144,756 | $2,174,235 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 350,877 | $1,866,666 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 1,604,466 | $1,732,823 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 595,024 | $1,564,913 | dollars as filed | |
| REIN THERAPEUTICS INC | 00887A204 | COM NEW | 1,660,197 | $1,334,798 | dollars as filed | |
| COYA THERAPEUTICS INC | 22407B108 | CMN | 229,600 | $1,150,296 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 168,383 | $1,148,372 | dollars as filed | |
| IMMUNEERING CORP | 45254E107 | CLASS A COM | 150,000 | $614,250 | dollars as filed | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 399,900 | $487,878 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-26-002713 | this filing | 2026-11-13 |